Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPN1 | P15169 | 3/20 | 0.51 |
| ▸ | CPB2 | Q96IY4 | 3/20 | 0.51 |
| ▸ | SLC6A1 | P30531 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | SLC6A11 | P48066 | 3/20 | 0.41 |
| ▸ | SLC6A13 | Q9NSD5 | 3/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | ACE | P12821 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | MITF | O75030 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25662157 | 0.94 | CPN1 (0.57) | CPN1CPB2SLC6A1SMN1; SMN2SLC6A11 | |
| SCHEMBL4189286 | 0.94 | CPN1 (0.57) | CPN1CPB2SLC6A1SMN1; SMN2SLC6A11 | |
| SCHEMBL25662164 | 0.94 | CPN1 (0.57) | CPN1CPB2SLC6A1SMN1; SMN2SLC6A11 | |
| SCHEMBL31167584 | 0.86 | CPN1 (0.44) | CPN1CPB2SLC6A1SMN1; SMN2SLC6A11 | |
| SCHEMBL27607144 | 0.86 | CPN1 (0.44) | CPN1CPB2SLC6A1SMN1; SMN2SLC6A11 | |
| SCHEMBL5499047 | 0.86 | CPN1 (0.44) | CPN1CPB2SLC6A1SMN1; SMN2SLC6A11 | |
| SCHEMBL29508636 | 0.86 | CPN1 (0.44) | CPN1CPB2SLC6A1SMN1; SMN2SLC6A11 | |
| Hydrochloric Acid SCHEMBL25263972 | 0.85 | CPN1 (0.43) | CPN1CPB2SLC6A1SMN1; SMN2SLC6A11 | |
| Hydrochloric Acid SCHEMBL31603105 | 0.85 | CPN1 (0.43) | CPN1CPB2SLC6A1SMN1; SMN2SLC6A11 | |
| Hydrochloric Acid SCHEMBL29508643 | 0.85 | CPN1 (0.43) | CPN1CPB2SLC6A1SMN1; SMN2SLC6A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070238721-A1 | Highly Selective Novel Amidation Method | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-10-11 | — | — | US | disclosed |
| WO-2007048918-A1 | NOVEL ESTERIFIED AMINO COMPOUNDS HAVING A HYDROCARBON RING E WITH SIX CAMPTOTHECIN ANALOGUE RING MEMBERS, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | LES LABORATOIRES SERVIER (FR) | 2007-05-03 | — | — | WO | disclosed |
| WO-2007048917-A1 | NOVEL ESTERIFIED AMINO COMPOUNDS HAVING A HYDROCARBON RING E WITH SEVEN CAMPTOTHECIN-DERIVED RING MEMBERS, PREPARATION METHOD THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME | LES LABORATOIRES SERVIER (FR) | 2007-05-03 | — | — | WO | disclosed |
| EP-1753752-A1 | HIGHLY SELECTIVE NOVEL AMIDATION METHOD | Takeda Pharmaceutical Company Limited (JP) | 2007-02-21 | — | — | EP | disclosed |
| WO-2005121133-A1 | HIGHLY SELECTIVE NOVEL AMIDATION METHOD | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070238721-A1 | Highly Selective Novel Amidation Method | NAAA, CPS1, COASY | CPN1 286/4885CPB2 559/4885SLC6A1 3877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.